Nepal on April 20 approved the use of the Russian anti-clotting vaccine Sputnik V in emergencies.
According to Reuters, in the winter, the country began to vaccinate the population with the drug AstraZeneca, but then its use was suspended due to supply disruptions.
The Sputnik V vaccine is registered in 60 countries. On the eve it became known that the effectiveness of the drug exceeded 97%.
It was reported today that Sputnik V, if approved by the European Medicines Agency, will not be available in the EU until the end of this year. At the same time, the Austrian government has already agreed on the purchase of the Russian vaccine.